• Issue

    Catheterization and Cardiovascular Interventions: Volume 77, Issue 7

    927-1086
    1 June 2011
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Coronary Artery Disease

Position Statement

Free Access

Quality assessment and improvement in interventional cardiology: A position statement of the Society of Cardiovascular Angiography and Interventions, part 1: Standards for quality assessment and improvement in interventional cardiology†

Lloyd W. Klein MD, FSCAI,  Barry F. Uretsky MD, FSCAI,  Charles Chambers MD, FSCAI,  H. Vernon Anderson MD, FSCAI,  William B. Hillegass MD, FSCAI,  Mandeep Singh MD, FSCAI,  Kalon K.L. Ho MD, MSc, FSCAI,  Sunil V. Rao MD, FSCAI,  John Reilly MD, FSCAI,  Bonnie H. Weiner MD, FSCAI,  Morton Kern MD, FSCAI,  Steven Bailey MD, FSCAI, 
  • Pages: 927-935
  • First Published: 02 March 2011

Original Studies

Validating the EXCEL hypothesis: A propensity score matched 3-year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32†

Davide Capodanno MD,  Anna Caggegi MD,  Piera Capranzano MD,  Glauco Cincotta MD,  Marco Miano MD,  Gionbattista Barrano MD,  Sergio Monaco MD,  Francesco Calvo MD,  Corrado Tamburino MD, PhD, 
  • Pages: 936-943
  • First Published: 05 May 2011

Editorial Comment

To excel or to confirm? That is the question†

George Dangas MD, FSCAI, 
  • Page: 944
  • First Published: 19 May 2011

Original Studies

Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function†

Michael S. Lee MD,  Tae Yang MD,  Giuseppe Biondi-Zoccai MD,  Dario Sillano MD,  Enrico Cerrato MD,  Giuseppe Tarantini MD,  Jola Xhaxho MD,  Joseph Aragon MD,  Imad Sheiban MD, 
  • Pages: 945-951
  • First Published: 07 September 2010

Editorial Comment

Left main and high-risk PCI: What, exactly, is it high risk for?†

Robert D. Safian MD, FSCAI, 
  • Pages: 952-953
  • First Published: 19 May 2011

Original Studies

Quality of life and health status after percutaneous coronary intervention in stable angina patients†: Results from the real-world practice

Alexandre S. de Quadros MD, PhD,  Tatiane C. Lima RN, MSc,  Ana Paula da Rosa Rodrigues MD,  Thais B. Modkovski MD,  Dulce I. Welter RN, MSc,  Rogério Sarmento-Leite MD, PhD,  Carlos A.M. Gottschall MD, PhD, 
  • Pages: 954-960
  • First Published: 07 September 2010

Editorial Comment

Effect of PCI on quality of life: “Good always triumphs”†

Carl L. Tommaso MD, 
  • Page: 961
  • First Published: 19 May 2011

Original Studies

Drug eluting versus bare metal stents in cardiac allograft vasculopathy†: A systematic review of literature

Tarun W. Dasari MD, MPH,  Thomas A. Hennebry MB BCh, BAO, FACC, FSCAI,  Elias B. Hanna MD,  Jorge F. Saucedo MD, FACC, 
  • Pages: 962-969
  • First Published: 16 March 2011

Editorial Comment

Drug-eluting stent implantation for the treatment of cardiac transplant vasculopathy: The jury is still out†

Jorge A. Belardi MD, FACC, FSCAI, 
  • Pages: 970-971
  • First Published: 19 May 2011

Original Studies

Frequency and risk of noncardiac surgery after drug-eluting stent implantation†

Nainesh K. Gandhi MD,  Abdul-Rahman R. Abdel-Karim MD,  Subhash Banerjee MD, FACC,  Emmanouil S. Brilakis MD, PhD, FACC, 
  • Pages: 972-976
  • First Published: 07 September 2010

Editorial Comment

The impact of noncardiac surgery on selection of a revascularization strategy†

Lowell F. Satler MD, 
  • Pages: 977-978
  • First Published: 19 May 2011

Original Studies

Usage patterns and 1-year outcomes with the TAXUS Liberté stent: Results of the TAXUS OLYMPIA registry†

Waqar H. Ahmed MD,  Oscar A. Mendiz MD,  Martyn R. Thomas MD,  for the TAXUS OLYMPIA Participating Physicians , 
  • Pages: 979-992
  • First Published: 17 September 2010

Extended follow-up safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: Two-year follow-up from the E-Five Registry

Ian Meredith MBBS, PhD,  Martin Rothman MB, ChB,  Andrejs Erglis MD, PhD,  Keyur Parikh MD,  Chaim Lotan MD,  for the E-Five Investigators , 
  • Pages: 993-1000
  • First Published: 17 September 2010

A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: The tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial†

David J. Moliterno MD,  and the TENACITY Steering Committee and Investigators , 
  • Pages: 1001-1009
  • First Published: 08 November 2010

Editorial Comment

Competing pharmacological strategies during PCI–analysis of a prematurely terminated trial†

Carey Kimmelstiel MD, 
  • Pages: 1010-1011
  • First Published: 19 May 2011

Original Studies

Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial†‡

Scot Garg MB, ChB, MRCP,  Patrick W. Serruys MD, PhD,  Karine Miquel-Hebert PhD,  on behalf of the SPIRIT II Investigators , 
  • Pages: 1012-1017
  • First Published: 07 September 2010

Editorial Comment

Each generation improves on the last (in cardiology): Bayesian thinking, the randomized clinical trial, and directed evolution†

Douglass A Morrison MD, PhD, 
  • Pages: 1018-1019
  • First Published: 19 May 2011

Original Studies

Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: A meta-analysis†

Dmitriy N. Feldman MD,  Luke Kim MD,  A. Garvey Rene MD,  Robert M. Minutello MD,  Geoffrey Bergman MD,  S. Chiu Wong MD, 
  • Pages: 1020-1030
  • First Published: 13 May 2011

Editorial Comment

Should serum troponin after PCI be used to predict long-term outcomes?…….Not quite yet!†

Barry F. Uretsky MD, 
  • Pages: 1031-1032
  • First Published: 19 May 2011

Case Report

Percutaneous coronary intervention of left main pseudoaneurysm with customized covered stents†

Sajid Dhakam MD, FACC, FSCAI,  Hafeez Ahmeed MBBS, FCPS,  Asif Jafarani, 
  • Pages: 1033-1035
  • First Published: 16 March 2011

Double-stent method†: An alternative technique to treat coronary artery aneurysms

Kavel Visrodia BS,  Ray Matthews MD,  Jabi Shriki MD, 
  • Pages: 1036-1041
  • First Published: 16 March 2011

Editorial Comment

Advances in the treatment of coronary artery aneurysms

Emmanouil S. Brilakis MD, PhD, FSCAI,  Subhash Banerjee MD, FSCAI, 
  • Pages: 1042-1044
  • First Published: 19 May 2011

Case Report

Supported percutaneous coronary intervention using a novel 6-Fr intra-aortic balloon pump catheter via the brachial artery in a nonagenarian patient with an abdominal aortic aneurysm†

Akihiko Takahashi MD, PhD,  Norimasa Taniguchi MD, 
  • Pages: 1045-1048
  • First Published: 16 March 2011

Editorial Comment

High-risk percutaneous coronary intervention: How far will 6-Fr take you?†

S. Hinan Ahmed, 
  • Page: 1049
  • First Published: 19 May 2011

Case Report

Radial access site inflammatory reaction to a recently available hydrophilic coated sheath†

Rajesh V. Swaminathan MD,  S. Chiu Wong MD, 
  • Pages: 1050-1053
  • First Published: 04 January 2011

Editorial Comment

Never say never†

Samuel M. Butman MD, FSCAI, 
  • Page: 1054
  • First Published: 19 May 2011

Peripheral Vascular Disease

Original Studies

Percutaneous revascularization of long femoral artery lesions for claudication†: Patency Over 2.5 years and impact of systematic surveillance

Gerard Connors MBBS,  Thomas M. Todoran MD,  Brian A. Engelson BS,  Piotr S. Sobieszczyk MD,  Andrew C. Eisenhauer MD,  Scott Kinlay MBBS, PhD, 
  • Pages: 1055-1062
  • First Published: 17 September 2010

Editorial Comment

What is lining your full metal jacket?

Bruce H. Gray DO, FSCAI, 
  • Pages: 1063-1064
  • First Published: 19 May 2011

Original Studies

Endovascular treatment of thrombosed dialysis fistulae†‡: A cumulative cost analysis

Pedro Bizarro MD,  Luís Coentrão MD,  Carlos Ribeiro BA,  Ricardo Neto MD,  Manuel Pestana MD, PhD, 
  • Pages: 1065-1070
  • First Published: 16 March 2011

Valvular and Structural Heart Diseases

Case Report

Sequential CoreValve implantation for a mal-positioned prosthesis during transcatheter aortic valve implantation†

Sea Hing Ong MBBS, MRCP,  Ralf Mueller MD,  Ulrich Gerckens MD, 
  • Pages: 1071-1075
  • First Published: 16 March 2011

Perforation of the descending thoracic aorta during transcatheter aortic valve implantation (TAVI): An unexpected and dramatic procedural complication†

Adel Aminian MD,  Jacques Lalmand MD,  Badih El Nakadi MD, 
  • Pages: 1076-1078
  • First Published: 28 April 2011

Basic Science

Limitations of closing percutaneous transthoracic ventricular access ports using a commercial collagen vascular closure device†

Israel M. Barbash MD,  Christina E. Saikus BS,  Kanishka Ratnayaka MD,  Anthony Z. Faranesh PhD,  Ozgur Kocaturk PhD,  Vincent Wu BS,  Jamie A. Bell BS,  William H. Schenke BS,  Venkatesh K. Raman MD,  Robert J. Lederman MD, 
  • Pages: 1079-1085
  • First Published: 13 January 2011

Letters to the Editor

Occlusion segment of the infarct-related artery†: A forgotten predictor of outcome in primary PCI

Lowell F. Satler MD, 
  • Page: 1086
  • First Published: 30 March 2011